SCHEMBL874738

SCHEMBL874738

CCNc1nc2nc[nH]c2c(=O)[nH]1

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
XDH P47989 3/20 0.74
GDA Q9Y2T3 1/20 0.62
POLA1 P09884 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667798 0.88 XDH (0.84) XDHGDAPOLA1
SCHEMBL9960821 0.87 XDH (0.69) XDHGDAPOLA1
SCHEMBL5935074 0.87 XDH (0.78) XDHGDAPOLA1
SCHEMBL6272738 0.85 XDH (1.00) XDHGDAPOLA1
SCHEMBL10421282 0.84 XDH (0.70) XDHGDAPOLA1
SCHEMBL1767753 0.84 XDH (0.66) XDHGDAPOLA1
SCHEMBL249649 0.84 XDH (1.00) XDHGDAPOLA1
SCHEMBL5503496 0.84 XDH (0.65) XDHGDA
SCHEMBL2343363 0.84 XDH (0.65) XDHGDA
SCHEMBL3428514 0.84 XDH (0.65) XDHGDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104447746-A Compound for activating AMPK and application thereof HUAAN MEDICAL CO LTD 2015-03-25 CN claimed
EP-1419247-A2 METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS Direvo Biotech AG (DE) 2004-05-19 EP claimed
WO-2003012100-A2 METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS DIREVO BIOTECH AG (DE) 2003-02-13 WO claimed
EP-4658754-A1 ALGAE BIOMASS Algenuity BV (NL) 2025-12-10 EP disclosed
EP-4658753-A1 CHLORELLA MICROALGAE Algenuity BV (NL) 2025-12-10 EP disclosed
EP-4658093-A1 FOOD COMPOSITION COMPRISING CHLOROPHYLL-DEFICIENT CHLORELLA BIOMASS WITH HIGH PROTEIN CONTENT >50WT% Unilever IP Holdings B.V. (NL) 2025-12-10 EP disclosed
EP-4658084-A1 FOOD COMPOSITION Unilever IP Holdings B.V. (NL) 2025-12-10 EP disclosed
WO-2025217194-A1 REPEAT DOSING OF RETROTRANSPOSONS TYPEWRITER THERAPEUTICS, INC. (US) 2025-10-16 WO disclosed
WO-2025082420-A1 AQUEOUS EMULSION, METHOD FOR PREPARING THE SAME, COATING COMPOSITION AND ARTICLE GUANGDONG HUARUN PAINTS CO., LTD. (CN) 2025-04-24 WO disclosed
EP-4522753-A2 DOUBLE STRANDED DNA COMPOSITIONS AND RELATED METHODS Flagship Pioneering Innovations VII, LLC (US) 2025-03-19 EP disclosed
US-20250027033-A1 MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION ALGENUITY HOLDINGS LTD (GB) 2025-01-23 US disclosed
EP-1290169-A2 CYSTINE-KNOT POLYPEPTIDES: CLOAKED-2 MOLECULES AND USES THEREOF Amgen, Inc. (US) 2003-03-12 EP disclosed
WO-2003012100-A2 METHOD FOR THE PRODUCTION OF NUCLEIC ACIDS CONSISTING OF STOCHASTICALLY COMBINED PARTS OF SOURCE NUCLEIC ACIDS DIREVO BIOTECH AG (DE) 2003-02-13 WO disclosed
WO-2001092308-A2 CYSTINE-KNOT POLYPEPTIDES: CLOAKED-2 MOLECULES AND USES THEREOF AMGEN, INC. (US) 2001-12-06 WO disclosed
WO-2001090314-A1 SHORT-ROOT GENE, PROMOTER, AND USES THEREOF NEW YORK UNIVERSITY (US) 2001-11-29 WO disclosed
EP-0666903-A4 INSULIN-DEPENDENT YEAST OR FUNGI. MCKENZIE MAUREEN A (US) 1997-06-04 EP disclosed
EP-0702683-A1 06-SUBSTITUTED GUANINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE IN TREATING TUMOUR CELLS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-03-27 EP disclosed
EP-0666903-A1 INSULIN-DEPENDENT YEAST OR FUNGI McKENZIE, Maureen A. (US) 1995-08-16 EP disclosed
WO-1994007994-A9 INSULIN-DEPENDENT YEAST OR FUNGI 1994-06-09 WO disclosed
WO-1994007994-A1 INSULIN-DEPENDENT YEAST OR FUNGI MCKENZIE MAUREEN A (US) 1994-04-14 WO disclosed